RhumbLine Advisers
VMD icon

RhumbLine Advisers’s Viemed Healthcare VMD Stock Holding History

RhumbLine Advisers’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$462K Sell
40,556
-262
-0.6% -$2.59K ﹤0.01% 2826
2026
Q1 		$376K Sell
40,818
-1,802
-4% -$15K ﹤0.01% 2787
2025
Q4 		$317K Sell
42,620
-5,976
-12% -$40.9K ﹤0.01% 2939
2025
Q3 		$330K Sell
48,596
-2,860
-6% -$19.4K ﹤0.01% 2933
2025
Q2 		$356K Buy
51,456
+4,228
+9% +$28.7K ﹤0.01% 2889
2025
Q1 		$344K Buy
47,228
+392
+0.8% +$3.08K ﹤0.01% 2810
2024
Q4 		$376K Buy
46,836
+6,275
+15% +$54.4K ﹤0.01% 2846
2024
Q3 		$297K Sell
40,561
-1,450
-3% -$10.4K ﹤0.01% 3032
2024
Q2 		$275K Buy
42,011
+3,613
+9% +$27.2K ﹤0.01% 3050
2024
Q1 		$362K Buy
38,398
+1,350
+4% +$11.6K ﹤0.01% 2866
2023
Q4 		$291K Sell
37,048
-954
-3% -$6.92K ﹤0.01% 2993
2023
Q3 		$256K Buy
38,002
+1,713
+5% +$14K ﹤0.01% 3017
2023
Q2 		$355K Buy
+36,289
New +$369K ﹤0.01% 2901
2022
Q2 		– Sell
-42,419
Closed -$211K – 3244
2022
Q1 		$211K Sell
42,419
-3,846
-8% -$17.9K ﹤0.01% 2743
2021
Q4 		$242K Sell
46,265
-223
-0.5% -$1.24K ﹤0.01% 2778
2021
Q3 		$258K Buy
46,488
+436
+0.9% +$2.84K ﹤0.01% 2825
2021
Q2 		$329K Buy
46,052
+9,109
+25% +$78.9K ﹤0.01% 2752
2021
Q1 		$374K Sell
36,943
-1,780
-5% -$16.8K ﹤0.01% 2620
2020
Q4 		$300K Buy
38,723
+3,064
+9% +$27K ﹤0.01% 2660
2020
Q3 		$308K Sell
35,659
-2,082
-6% -$21K ﹤0.01% 2509
2020
Q2 		$362K Buy
+37,741
New +$293K ﹤0.01% 2475

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

RhumbLine Advisers's VMD Position: Q2 2026 in Review

RhumbLine Advisers reduced its Viemed Healthcare (VMD) stake by 0.64% in Q2 2026, selling an estimated $2.59K and leaving 40,556 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2826.

RhumbLine Advisers first reported a position in VMD in Q2 2020 and has held it in 21 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • RhumbLine Advisers held 40,556 shares of Viemed Healthcare worth $462K as of Q2 2026.
  • RhumbLine Advisers sold 262 Viemed Healthcare shares in Q2 2026, an estimated $2.59K.
  • Viemed Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2826 holding.
  • RhumbLine Advisers first reported a position in Viemed Healthcare in Q2 2020 and has held it in 21 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.